FORTICAL
Dead / Cancelled — Cancelled — Section 8 (as of 10 Dec 2021)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 74608739
- Registration number
- 2457466
- Mark type
- Word mark
- Filed
- 08 Dec 1994
- Published for opposition
- 22 Aug 1995
- Registered
- 05 Jun 2001
- Next maintenance due
- 05 Jun 2011
- Attorney of record
- CHARLES P. LAPOLLA
Goods and services
- Class 005 — Pharmaceuticals: prescription pharmaceutical preparation for the treatment of osteoporosis
Owner
- ENTERIS BIOPHARMA, INC., BOONTON, NJ, US
- UGP THERAPEUTICS, INC., CHICAGO, IL, US
- Unigene Laboratories, Inc., BOONTON, NJ, US
- Unigene Laboratories, Inc., Fairfield, NJ, US
- Unigene Laboratories, Inc., Fairfield, NJ, US
Prosecution history
- 10 Dec 2021 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 10 Aug 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 11 Jun 2014 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 16 Feb 2011 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 16 Feb 2011 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 04 Feb 2011 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 04 Feb 2011 — PAPER RECEIVED
- 20 Oct 2006 — CASE FILE IN TICRS
- 20 Sept 2006 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 18 Sept 2006 — ASSIGNED TO PARALEGAL
- 23 Jun 2006 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 23 Jun 2006 — PAPER RECEIVED
- 05 Jun 2001 — REGISTERED-PRINCIPAL REGISTER
- 22 Jan 2001 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Jan 2001 — ASSIGNED TO EXAMINER